BMY

Bristol-Myers Squibb CompanyNYSEHealthcare

$59.60-3.45%OpenMarket Cap: $121.37B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-17	HSBC	—	Hold	—
2026-02-23	Piper Sandler	—	Overweight	—
2026-02-06	Citigroup	—	Neutral	—
2026-02-06	Guggenheim	—	Buy	—
2026-02-06	Wells Fargo	—	Equal Weight	—
2026-01-13	Leerink Partners	—	Outperform	—
2026-01-09	Scotiabank	—	Sector Perform	—
2026-01-07	UBS	—	Buy	—
2025-12-15	B of A Securities	—	Buy	—
2025-12-12	Guggenheim	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$6.13	$45.97B	16
Sun Dec 31	$5.45	$40.75B	10
Mon Dec 31	$4.91	$37.07B	4
Tue Dec 31	$4.89	$36.42B	4